SCHEMBL14486804

SCHEMBL14486804

COc1ccc(Sc2ccc(Sc3ccc(OC)cc3)c(N)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 3/20 0.49
MAPT P10636 6/20 0.47
ALDH1A1 P00352 6/20 0.47
HPGD P15428 4/20 0.47
KDM4E B2RXH2 4/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
MAPK1 P28482 3/20 0.47
LMNA P02545 2/20 0.47
ALOX15 P16050 2/20 0.47
HSD17B10 Q99714 2/20 0.47
NPSR1 Q6W5P4 1/20 0.46
SLC6A2 P23975 2/20 0.44
SLC6A4 P31645 2/20 0.44
SLC6A3 Q01959 2/20 0.44
DHFR P00374 1/20 0.44
TDP1 Q9NUW8 4/20 0.44
GAA P10253 2/20 0.44
TP53 P04637 1/20 0.44
HTR1A P08908 2/20 0.43
HTR3A P46098 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL810329 0.86 ALDH1A1 (0.55) PTGIRMAPTALDH1A1HPGDKDM4E
SCHEMBL2970197 0.81 SLC6A2 (0.57) MAPTALDH1A1HPGDKDM4EL3MBTL1
SCHEMBL8964803 0.80 MEN1 (0.54) PTGIRMAPTALDH1A1HPGDKDM4E
SCHEMBL20591221 0.80 MAPT (0.59) PTGIRMAPTALDH1A1HPGDKDM4E
SCHEMBL19041461 0.79 CYP3A4 (0.61) MAPTALDH1A1HPGDKDM4EL3MBTL1
SCHEMBL1454782 0.79 MAPT (0.78) PTGIRMAPTALDH1A1HPGDKDM4E
SCHEMBL10558215 0.78 SLC6A2 (0.48) MAPTALDH1A1HPGDKDM4EL3MBTL1
SCHEMBL482369 0.78 CA1 (0.65) PTGIRMAPTALDH1A1KDM4EL3MBTL1
SCHEMBL29217096 0.77 ALDH1A1 (0.47) MAPTALDH1A1HPGDKDM4EL3MBTL1
SCHEMBL5786907 0.77 TDP1 (0.73) PTGIRMAPTALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013005157-A1 SULFONE DERIVATIVES AND THEIR USE AS PKM2 MODULATORS FOR THE TREATMENT OF CANCER LUPIN LIMITED (IN) 2013-01-10 WO disclosed
WO-2013005157-A1 SULFONE DERIVATIVES AND THEIR USE AS PKM2 MODULATORS FOR THE TREATMENT OF CANCER LUPIN LIMITED (IN) 2013-01-10 WO disclosed